

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of neuron projection regeneration (GO:0070570) | 8.38318600 |
| 2 | regulation of axon regeneration (GO:0048679) | 8.38318600 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 7.28778666 |
| 4 | locomotory exploration behavior (GO:0035641) | 6.87737310 |
| 5 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.76150673 |
| 6 | regulation of transmission of nerve impulse (GO:0051969) | 6.51883761 |
| 7 | peptidyl-threonine dephosphorylation (GO:0035970) | 6.00545411 |
| 8 | postsynaptic membrane organization (GO:0001941) | 5.68560591 |
| 9 | nucleobase catabolic process (GO:0046113) | 5.58509324 |
| 10 | meiotic chromosome segregation (GO:0045132) | 5.42366125 |
| 11 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 5.38955840 |
| 12 | presynaptic membrane assembly (GO:0097105) | 5.21206100 |
| 13 | cerebral cortex radially oriented cell migration (GO:0021799) | 5.19885811 |
| 14 | positive regulation of neurological system process (GO:0031646) | 5.06981418 |
| 15 | protein K11-linked deubiquitination (GO:0035871) | 4.85190209 |
| 16 | regulation of synapse maturation (GO:0090128) | 4.85101399 |
| 17 | protein localization to synapse (GO:0035418) | 4.60158414 |
| 18 | auditory behavior (GO:0031223) | 4.42675657 |
| 19 | negative regulation of axon extension (GO:0030517) | 4.38166567 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37883780 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.29868799 |
| 22 | positive regulation of amino acid transport (GO:0051957) | 4.28394265 |
| 23 | glycosphingolipid biosynthetic process (GO:0006688) | 4.26746915 |
| 24 | L-fucose catabolic process (GO:0042355) | 4.22121051 |
| 25 | fucose catabolic process (GO:0019317) | 4.22121051 |
| 26 | L-fucose metabolic process (GO:0042354) | 4.22121051 |
| 27 | snRNA processing (GO:0016180) | 4.18427902 |
| 28 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.14005840 |
| 29 | inositol metabolic process (GO:0006020) | 4.06035538 |
| 30 | exploration behavior (GO:0035640) | 4.04703446 |
| 31 | lysine metabolic process (GO:0006553) | 4.03614752 |
| 32 | lysine catabolic process (GO:0006554) | 4.03614752 |
| 33 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 4.02913504 |
| 34 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 4.02913504 |
| 35 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.78089355 |
| 36 | snRNA metabolic process (GO:0016073) | 3.74130221 |
| 37 | mechanosensory behavior (GO:0007638) | 3.65018751 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.64339901 |
| 39 | rRNA catabolic process (GO:0016075) | 3.63838559 |
| 40 | mitochondrion degradation (GO:0000422) | 3.63721025 |
| 41 | acrosome assembly (GO:0001675) | 3.50766446 |
| 42 | vocalization behavior (GO:0071625) | 3.50117098 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.49165866 |
| 44 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.48938222 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.46646690 |
| 46 | kynurenine metabolic process (GO:0070189) | 3.40625480 |
| 47 | central nervous system neuron axonogenesis (GO:0021955) | 3.38250805 |
| 48 | carbohydrate phosphorylation (GO:0046835) | 3.37886362 |
| 49 | tryptophan catabolic process (GO:0006569) | 3.35135909 |
| 50 | indole-containing compound catabolic process (GO:0042436) | 3.35135909 |
| 51 | indolalkylamine catabolic process (GO:0046218) | 3.35135909 |
| 52 | telencephalon development (GO:0021537) | 3.30744616 |
| 53 | telencephalon cell migration (GO:0022029) | 3.29967177 |
| 54 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.28159696 |
| 55 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.28159696 |
| 56 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.28159696 |
| 57 | cell migration in hindbrain (GO:0021535) | 3.27093291 |
| 58 | dendrite morphogenesis (GO:0048813) | 3.25097074 |
| 59 | gamma-aminobutyric acid transport (GO:0015812) | 3.24716376 |
| 60 | nerve growth factor signaling pathway (GO:0038180) | 3.23266433 |
| 61 | histone H3-K4 trimethylation (GO:0080182) | 3.23054052 |
| 62 | negative regulation of axonogenesis (GO:0050771) | 3.22829532 |
| 63 | startle response (GO:0001964) | 3.15839883 |
| 64 | motor neuron axon guidance (GO:0008045) | 3.15238755 |
| 65 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.12629837 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.12161306 |
| 67 | forebrain cell migration (GO:0021885) | 3.09907023 |
| 68 | reciprocal DNA recombination (GO:0035825) | 3.05459713 |
| 69 | reciprocal meiotic recombination (GO:0007131) | 3.05459713 |
| 70 | auditory receptor cell stereocilium organization (GO:0060088) | 3.05171841 |
| 71 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.05120247 |
| 72 | negative regulation of astrocyte differentiation (GO:0048712) | 3.02520224 |
| 73 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.01666567 |
| 74 | synaptic transmission, glutamatergic (GO:0035249) | 3.01512935 |
| 75 | granulocyte differentiation (GO:0030851) | 3.00999556 |
| 76 | N-glycan processing (GO:0006491) | 3.00216887 |
| 77 | central nervous system myelination (GO:0022010) | 2.97390618 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 2.97390618 |
| 79 | ganglioside metabolic process (GO:0001573) | 2.93008317 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 2.92888203 |
| 81 | positive regulation of heat generation (GO:0031652) | 2.92635906 |
| 82 | Golgi to endosome transport (GO:0006895) | 2.86144829 |
| 83 | response to auditory stimulus (GO:0010996) | 2.84929382 |
| 84 | response to inactivity (GO:0014854) | 2.84377140 |
| 85 | regulation of Rac GTPase activity (GO:0032314) | 2.83380698 |
| 86 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.82096156 |
| 87 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.81414299 |
| 88 | inner ear receptor stereocilium organization (GO:0060122) | 2.81011680 |
| 89 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79178734 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.72945457 |
| 91 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.72612800 |
| 92 | N-acetylneuraminate metabolic process (GO:0006054) | 2.72430916 |
| 93 | regulation of glutamate secretion (GO:0014048) | 2.71602595 |
| 94 | sialylation (GO:0097503) | 2.69060735 |
| 95 | cerebral cortex cell migration (GO:0021795) | 2.68594388 |
| 96 | spinal cord motor neuron differentiation (GO:0021522) | 2.64938096 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 2.63121347 |
| 98 | import into cell (GO:0098657) | 2.62126619 |
| 99 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.61546715 |
| 100 | neuron fate determination (GO:0048664) | 2.61288190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89646604 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53007003 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.83598781 |
| 4 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.80489816 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.60342878 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.54181177 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.52951651 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.50027576 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.41074387 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.35652168 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.25228912 |
| 12 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.19891708 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.11229415 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09966962 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.07717000 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94309454 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91159286 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90489084 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.87704711 |
| 20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85217161 |
| 21 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83231919 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.78897544 |
| 23 | TCF4_23295773_ChIP-Seq_U87_Human | 1.75435237 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74428282 |
| 25 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.73017308 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.73017308 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71405399 |
| 28 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.70930342 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70930342 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.68883712 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.64755406 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56632925 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52679971 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.50083715 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47509777 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47030016 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42300079 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42056753 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41993700 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.41888977 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39867057 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35451694 |
| 43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32138743 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.31309143 |
| 45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30129011 |
| 46 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30101428 |
| 47 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.29530511 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29431862 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27035521 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27025964 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25527020 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25247039 |
| 53 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.23358341 |
| 54 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23296264 |
| 55 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22475653 |
| 56 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21366139 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.20831084 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20208684 |
| 59 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.19411797 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18840547 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17824535 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17047506 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15597003 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14902052 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14302660 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14180632 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13322959 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10530768 |
| 69 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09590092 |
| 70 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09417816 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.08869480 |
| 72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08859472 |
| 73 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08801041 |
| 74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07818496 |
| 75 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06973960 |
| 76 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.06648110 |
| 77 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.06477264 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06195682 |
| 79 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06180063 |
| 80 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05964304 |
| 81 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05712432 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04828009 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04539003 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04539003 |
| 85 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04256974 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03362391 |
| 87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02342235 |
| 88 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02231446 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 1.01413898 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00950861 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99457420 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98938274 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98361679 |
| 94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97974591 |
| 95 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97919655 |
| 96 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97633275 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.97195311 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97031226 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96746551 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96513480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 4.69119249 |
| 2 | MP0002736_abnormal_nociception_after | 4.57752181 |
| 3 | MP0001986_abnormal_taste_sensitivity | 4.18664436 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.89028958 |
| 5 | MP0002735_abnormal_chemical_nociception | 2.95213990 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.93534165 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.90146643 |
| 8 | MP0000631_abnormal_neuroendocrine_gland | 2.70103848 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.57529715 |
| 10 | MP0004885_abnormal_endolymph | 2.48374884 |
| 11 | MP0004270_analgesia | 2.40660497 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.23573825 |
| 13 | MP0009745_abnormal_behavioral_response | 2.08016140 |
| 14 | MP0003136_yellow_coat_color | 2.04900107 |
| 15 | MP0005187_abnormal_penis_morphology | 2.03929803 |
| 16 | MP0008872_abnormal_physiological_respon | 1.99591995 |
| 17 | MP0002063_abnormal_learning/memory/cond | 1.99027901 |
| 18 | MP0002272_abnormal_nervous_system | 1.95812229 |
| 19 | MP0004484_altered_response_of | 1.92355172 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.92242637 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 1.90813082 |
| 22 | MP0001970_abnormal_pain_threshold | 1.90544785 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.87081192 |
| 24 | MP0002064_seizures | 1.86279960 |
| 25 | MP0009046_muscle_twitch | 1.80303976 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.76515745 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.75385940 |
| 28 | MP0004924_abnormal_behavior | 1.75385940 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.74754098 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.71580560 |
| 31 | MP0001188_hyperpigmentation | 1.69314609 |
| 32 | MP0003195_calcinosis | 1.61974872 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.54216977 |
| 34 | MP0001486_abnormal_startle_reflex | 1.49471694 |
| 35 | MP0003632_abnormal_nervous_system | 1.49428344 |
| 36 | MP0002067_abnormal_sensory_capabilities | 1.47915088 |
| 37 | MP0000778_abnormal_nervous_system | 1.47781215 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.46899426 |
| 39 | MP0002160_abnormal_reproductive_system | 1.41915947 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.40641709 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.36025673 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.33760844 |
| 43 | MP0004742_abnormal_vestibular_system | 1.30960276 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.28942320 |
| 45 | MP0003646_muscle_fatigue | 1.27220115 |
| 46 | MP0003631_nervous_system_phenotype | 1.26788505 |
| 47 | MP0002184_abnormal_innervation | 1.25770292 |
| 48 | MP0003880_abnormal_central_pattern | 1.24962990 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.23341002 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.22030650 |
| 51 | MP0005310_abnormal_salivary_gland | 1.21770108 |
| 52 | MP0005171_absent_coat_pigmentation | 1.21182427 |
| 53 | MP0004142_abnormal_muscle_tone | 1.18959545 |
| 54 | MP0004147_increased_porphyrin_level | 1.17921531 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.16207789 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.10724634 |
| 57 | MP0004381_abnormal_hair_follicle | 1.09288235 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09087354 |
| 59 | MP0000751_myopathy | 1.06625613 |
| 60 | MP0002229_neurodegeneration | 1.06119207 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.04787417 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.04768273 |
| 63 | MP0002751_abnormal_autonomic_nervous | 1.04638581 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.04509168 |
| 65 | MP0004130_abnormal_muscle_cell | 1.03891527 |
| 66 | MP0002152_abnormal_brain_morphology | 1.03342780 |
| 67 | MP0003315_abnormal_perineum_morphology | 0.97236352 |
| 68 | MP0000955_abnormal_spinal_cord | 0.95906596 |
| 69 | MP0005389_reproductive_system_phenotype | 0.94247459 |
| 70 | MP0003633_abnormal_nervous_system | 0.93917122 |
| 71 | MP0004133_heterotaxia | 0.93249047 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 0.90256039 |
| 73 | MP0001440_abnormal_grooming_behavior | 0.88946330 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 0.88666526 |
| 75 | MP0002752_abnormal_somatic_nervous | 0.87931540 |
| 76 | MP0001984_abnormal_olfaction | 0.87477086 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.87324593 |
| 78 | MP0006292_abnormal_olfactory_placode | 0.86285574 |
| 79 | MP0001764_abnormal_homeostasis | 0.85542254 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.84943890 |
| 81 | MP0005410_abnormal_fertilization | 0.82338353 |
| 82 | MP0005408_hypopigmentation | 0.81927025 |
| 83 | MP0000920_abnormal_myelination | 0.79994713 |
| 84 | MP0003011_delayed_dark_adaptation | 0.79601861 |
| 85 | MP0005195_abnormal_posterior_eye | 0.79129560 |
| 86 | MP0001919_abnormal_reproductive_system | 0.78623156 |
| 87 | MP0005332_abnormal_amino_acid | 0.78178543 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.78058186 |
| 89 | MP0000427_abnormal_hair_cycle | 0.77978205 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.77092166 |
| 91 | MP0009764_decreased_sensitivity_to | 0.73225690 |
| 92 | MP0003115_abnormal_respiratory_system | 0.72885574 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.72805621 |
| 94 | MP0003634_abnormal_glial_cell | 0.72400749 |
| 95 | MP0004085_abnormal_heartbeat | 0.70546877 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.70511342 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.69846766 |
| 98 | MP0004084_abnormal_cardiac_muscle | 0.69774235 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.68213964 |
| 100 | MP0005253_abnormal_eye_physiology | 0.66181343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Septo-optic dysplasia (HP:0100842) | 8.94367693 |
| 2 | Optic nerve hypoplasia (HP:0000609) | 5.50297445 |
| 3 | Abnormality of the septum pellucidum (HP:0007375) | 4.92018146 |
| 4 | Abnormality of the sella turcica (HP:0002679) | 4.90558822 |
| 5 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 4.71095629 |
| 6 | Absent septum pellucidum (HP:0001331) | 4.65185005 |
| 7 | Hyperventilation (HP:0002883) | 4.16984325 |
| 8 | Stomach cancer (HP:0012126) | 3.97832555 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.88458569 |
| 10 | True hermaphroditism (HP:0010459) | 3.81965747 |
| 11 | Broad-based gait (HP:0002136) | 3.79171587 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.60135542 |
| 13 | Pancreatic cysts (HP:0001737) | 3.57607034 |
| 14 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 3.44055014 |
| 15 | Rimmed vacuoles (HP:0003805) | 3.39481646 |
| 16 | Congenital stationary night blindness (HP:0007642) | 3.33339026 |
| 17 | Medial flaring of the eyebrow (HP:0010747) | 3.30401269 |
| 18 | Nephronophthisis (HP:0000090) | 3.21926963 |
| 19 | Lissencephaly (HP:0001339) | 3.12086474 |
| 20 | Growth hormone deficiency (HP:0000824) | 3.08333964 |
| 21 | Protruding tongue (HP:0010808) | 3.07708404 |
| 22 | Abnormality of midbrain morphology (HP:0002418) | 3.02984197 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 3.02984197 |
| 24 | Gait imbalance (HP:0002141) | 2.93585996 |
| 25 | Progressive inability to walk (HP:0002505) | 2.87891094 |
| 26 | Attenuation of retinal blood vessels (HP:0007843) | 2.87169749 |
| 27 | Congenital primary aphakia (HP:0007707) | 2.72551572 |
| 28 | Cerebellar dysplasia (HP:0007033) | 2.72339706 |
| 29 | Focal seizures (HP:0007359) | 2.71490016 |
| 30 | Focal motor seizures (HP:0011153) | 2.70426425 |
| 31 | Bile duct proliferation (HP:0001408) | 2.66711626 |
| 32 | Abnormal biliary tract physiology (HP:0012439) | 2.66711626 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.59660181 |
| 34 | Abnormality of the renal medulla (HP:0100957) | 2.57220500 |
| 35 | Cystic liver disease (HP:0006706) | 2.55286623 |
| 36 | Drooling (HP:0002307) | 2.54144087 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 2.52642698 |
| 38 | Alveolar cell carcinoma (HP:0006519) | 2.48167689 |
| 39 | Amblyopia (HP:0000646) | 2.47530208 |
| 40 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47223194 |
| 41 | Type II lissencephaly (HP:0007260) | 2.45724886 |
| 42 | Agitation (HP:0000713) | 2.43516341 |
| 43 | Decreased circulating renin level (HP:0003351) | 2.40465711 |
| 44 | Thyroid-stimulating hormone excess (HP:0002925) | 2.38838910 |
| 45 | Biliary tract neoplasm (HP:0100574) | 2.38333890 |
| 46 | Furrowed tongue (HP:0000221) | 2.38185608 |
| 47 | Excessive salivation (HP:0003781) | 2.34630832 |
| 48 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.30356174 |
| 49 | Primary amenorrhea (HP:0000786) | 2.28307619 |
| 50 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28290512 |
| 51 | Abnormality of alanine metabolism (HP:0010916) | 2.28290512 |
| 52 | Hyperalaninemia (HP:0003348) | 2.28290512 |
| 53 | Pachygyria (HP:0001302) | 2.24763538 |
| 54 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23125214 |
| 55 | Coronal craniosynostosis (HP:0004440) | 2.21155105 |
| 56 | Megalencephaly (HP:0001355) | 2.20678385 |
| 57 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.18312524 |
| 58 | Primary adrenal insufficiency (HP:0008207) | 2.18191813 |
| 59 | Poor coordination (HP:0002370) | 2.16924532 |
| 60 | Pigmentary retinal degeneration (HP:0001146) | 2.14512346 |
| 61 | Vaginal atresia (HP:0000148) | 2.13377278 |
| 62 | Occipital encephalocele (HP:0002085) | 2.12739933 |
| 63 | Bundle branch block (HP:0011710) | 2.12021349 |
| 64 | Dialeptic seizures (HP:0011146) | 2.12020732 |
| 65 | Congenital hepatic fibrosis (HP:0002612) | 2.05507041 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.05228020 |
| 67 | Inability to walk (HP:0002540) | 2.04927711 |
| 68 | Abnormality of the renal cortex (HP:0011035) | 2.04795652 |
| 69 | Sclerocornea (HP:0000647) | 2.04744985 |
| 70 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.04732752 |
| 71 | Chorioretinal atrophy (HP:0000533) | 2.02982180 |
| 72 | Anencephaly (HP:0002323) | 2.01930984 |
| 73 | Ketosis (HP:0001946) | 2.00854185 |
| 74 | Choroideremia (HP:0001139) | 2.00362732 |
| 75 | Genital tract atresia (HP:0001827) | 1.99362066 |
| 76 | Febrile seizures (HP:0002373) | 1.95576649 |
| 77 | Retinitis pigmentosa (HP:0000510) | 1.93829462 |
| 78 | Heterotopia (HP:0002282) | 1.90678536 |
| 79 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.89601204 |
| 80 | Polydipsia (HP:0001959) | 1.88962115 |
| 81 | Abnormal drinking behavior (HP:0030082) | 1.88962115 |
| 82 | Severe Myopia (HP:0011003) | 1.83766588 |
| 83 | Tubular atrophy (HP:0000092) | 1.82351685 |
| 84 | Intestinal atresia (HP:0011100) | 1.78882126 |
| 85 | Chronic bronchitis (HP:0004469) | 1.78093189 |
| 86 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.76147558 |
| 87 | Hypoplasia of the brainstem (HP:0002365) | 1.76147558 |
| 88 | Polymicrogyria (HP:0002126) | 1.74521922 |
| 89 | Specific learning disability (HP:0001328) | 1.71903594 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71048686 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 1.70713965 |
| 92 | Abnormal biliary tract morphology (HP:0012440) | 1.70240448 |
| 93 | Intellectual disability, severe (HP:0010864) | 1.70234602 |
| 94 | Hamartoma of the eye (HP:0010568) | 1.69892705 |
| 95 | Conical tooth (HP:0000698) | 1.68026628 |
| 96 | Postaxial foot polydactyly (HP:0001830) | 1.65928838 |
| 97 | Atonic seizures (HP:0010819) | 1.65848145 |
| 98 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.65690262 |
| 99 | Hypoplasia of the fovea (HP:0007750) | 1.65690262 |
| 100 | Decreased central vision (HP:0007663) | 1.65030847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.40914780 |
| 2 | MARK1 | 4.79969095 |
| 3 | BLK | 4.12635391 |
| 4 | ERBB4 | 3.50435471 |
| 5 | MAP3K9 | 3.10276527 |
| 6 | MAP4K2 | 3.02659313 |
| 7 | FRK | 2.65376141 |
| 8 | IRAK2 | 2.63784941 |
| 9 | DYRK2 | 2.17143515 |
| 10 | MAPK13 | 1.98020168 |
| 11 | IRAK1 | 1.95095323 |
| 12 | MAP2K7 | 1.94259021 |
| 13 | PINK1 | 1.87418577 |
| 14 | NTRK2 | 1.84069275 |
| 15 | CAMKK2 | 1.75686900 |
| 16 | YES1 | 1.54618493 |
| 17 | CAMK1D | 1.51300814 |
| 18 | MAP3K4 | 1.46202685 |
| 19 | TNIK | 1.42182449 |
| 20 | EPHA4 | 1.39676719 |
| 21 | TAOK3 | 1.31899196 |
| 22 | ADRBK2 | 1.28453834 |
| 23 | DAPK2 | 1.26092220 |
| 24 | SGK2 | 1.23683430 |
| 25 | MKNK2 | 1.19232651 |
| 26 | NUAK1 | 1.18219221 |
| 27 | SGK223 | 1.17035679 |
| 28 | SGK494 | 1.17035679 |
| 29 | DYRK3 | 1.15137423 |
| 30 | RPS6KB2 | 1.11090325 |
| 31 | CAMK1G | 1.04466104 |
| 32 | CAMK4 | 1.02175460 |
| 33 | PBK | 0.92048095 |
| 34 | ARAF | 0.87182074 |
| 35 | RPS6KA4 | 0.85559964 |
| 36 | PAK3 | 0.84578701 |
| 37 | WNK4 | 0.83127343 |
| 38 | WNK3 | 0.79458806 |
| 39 | NTRK3 | 0.77167383 |
| 40 | GSK3A | 0.74901955 |
| 41 | PDPK1 | 0.72727708 |
| 42 | PDK1 | 0.72507805 |
| 43 | ROCK1 | 0.72224728 |
| 44 | MAP2K4 | 0.71227824 |
| 45 | SGK3 | 0.70178451 |
| 46 | CAMK2B | 0.67979273 |
| 47 | ERBB2 | 0.66243759 |
| 48 | CDK5 | 0.66004182 |
| 49 | LATS1 | 0.64243456 |
| 50 | OBSCN | 0.62714923 |
| 51 | MAPKAPK5 | 0.61068569 |
| 52 | MAPK15 | 0.59066445 |
| 53 | PKN1 | 0.58442688 |
| 54 | PRKCG | 0.56991561 |
| 55 | STK16 | 0.56240093 |
| 56 | PRKCE | 0.54864415 |
| 57 | CSNK1G2 | 0.54413023 |
| 58 | RAF1 | 0.54377511 |
| 59 | ADRBK1 | 0.53203165 |
| 60 | ZAK | 0.52371126 |
| 61 | MAP3K13 | 0.51712907 |
| 62 | MKNK1 | 0.50895902 |
| 63 | CSNK1A1L | 0.50696330 |
| 64 | GRK1 | 0.49212284 |
| 65 | CAMKK1 | 0.49003063 |
| 66 | STK39 | 0.47461455 |
| 67 | CSNK1G1 | 0.43624087 |
| 68 | CAMK1 | 0.43505866 |
| 69 | AKT3 | 0.43317979 |
| 70 | CAMK2A | 0.41187133 |
| 71 | SGK1 | 0.41085687 |
| 72 | HIPK2 | 0.40958116 |
| 73 | CAMK2D | 0.40840434 |
| 74 | BCR | 0.40826246 |
| 75 | MARK3 | 0.40069398 |
| 76 | CSNK1G3 | 0.38100606 |
| 77 | TYRO3 | 0.35350112 |
| 78 | LYN | 0.34797014 |
| 79 | PHKG1 | 0.33373623 |
| 80 | PHKG2 | 0.33373623 |
| 81 | TNK2 | 0.33080722 |
| 82 | KSR1 | 0.33002146 |
| 83 | DMPK | 0.32634077 |
| 84 | PRKG1 | 0.32307319 |
| 85 | SIK2 | 0.31419187 |
| 86 | PDGFRB | 0.30817684 |
| 87 | PDK2 | 0.30720120 |
| 88 | CSNK1E | 0.30179364 |
| 89 | IGF1R | 0.29862676 |
| 90 | CAMK2G | 0.29200370 |
| 91 | PLK2 | 0.28315133 |
| 92 | RPS6KB1 | 0.28136306 |
| 93 | PIK3CG | 0.26731902 |
| 94 | ERBB3 | 0.26104789 |
| 95 | PRKD1 | 0.25901182 |
| 96 | TRPM7 | 0.25680471 |
| 97 | GRK5 | 0.25173288 |
| 98 | MAP3K7 | 0.25056178 |
| 99 | NEK2 | 0.24299535 |
| 100 | PRKCQ | 0.24051189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.28551575 |
| 2 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.10780195 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46220427 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.36803379 |
| 5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.30818035 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.27859880 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.04826574 |
| 8 | Long-term depression_Homo sapiens_hsa04730 | 1.99807901 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80048818 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77874229 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77743194 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.74523490 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.73720380 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72122903 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71580825 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66489484 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66159590 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.61201005 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.58940769 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56632850 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56136223 |
| 22 | Lysine degradation_Homo sapiens_hsa00310 | 1.55589406 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51289152 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48657119 |
| 25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43092141 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.42190302 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40306693 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40032244 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36543851 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.36125636 |
| 31 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.27569436 |
| 32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.25024405 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24626562 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24267359 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22665024 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21945521 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18044067 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.17005653 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16955665 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14829378 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.11611571 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10203691 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09988190 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07662623 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07599932 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07166844 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.04512096 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02748709 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00269178 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99627107 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98269891 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.97918188 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95282450 |
| 54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95111604 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90426201 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.90310569 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89753731 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89576719 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88667542 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88500088 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87640175 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84643855 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80751022 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78653510 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78200982 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 0.74477521 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70043769 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69312975 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.68270207 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65238937 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62504507 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61124872 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59589320 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57474285 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57242763 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57176175 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53760381 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53292431 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51440347 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50161976 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49040187 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48073505 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47845753 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.46326203 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42563037 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42356504 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.41467607 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.41345094 |
| 89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40164706 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39629756 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37731731 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35902549 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35556369 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35259684 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32460658 |
| 96 | Melanogenesis_Homo sapiens_hsa04916 | 0.31841278 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31089890 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.30956845 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.30658834 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30602569 |

